We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+12.49%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$164M
AUM Growth
+$23M
(+16%)
Cap. Flow
+$2.36M
Cap. Flow
% of AUM
1.44%
Top 10 Holdings %
Top 10 Hldgs %
37.28%
Holding
392
New
88
Increased
30
Reduced
44
Closed
76
Avg Time Held Equity + Options
0.7
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
0.7
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$1.44M |
| 2 |
FMI
Foundation Medicine, Inc.
FMI
|
+$935K |
| 3 |
SFLY
Shutterfly, Inc.
SFLY
|
+$834K |
| 4 |
IMPV
Imperva, Inc.
IMPV
|
+$834K |
| 5 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$777K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$2.59M |
| 2 |
Columbia Banking Systems
COLB
|
+$1.35M |
| 3 |
Weyerhaeuser
WY
|
+$943K |
| 4 |
The ExOne Company
XONE
|
+$940K |
| 5 |
Noodles & Co
NDLS
|
+$919K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.49% |
| 2 | Financials | 29.11% |
| 3 | Healthcare | 10.89% |
| 4 | Technology | 9.06% |
| 5 | Consumer Discretionary | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ROX
201
DELISTED
Castle Brands, Inc.
ROX
| $57K | 0.03% |
75,000
+25,000
| +50% | +$11.3K |
2013 Q2
1 quarter
|
|
202
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $50K | 0.03% |
28,400
-8,400
| -23% | -$17.8K |
2013 Q2
1 quarter
|
|
|
ANTH
203
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $50K | 0.03% |
1,562
-1
| -0.1% | -$31 |
2013 Q2
1 quarter
|
|
204
Pure Cycle
PCYO
$271M
| $46K | 0.03% |
10,000
| – | – |
2013 Q2
1 quarter
|
|
|
TCF.WS
205
DELISTED
TCF Financial Corporation
TCF.WS
| $37K | 0.02% |
15,900
-4,600
| -22% | -$11.8K |
2013 Q2
1 quarter
|
|
206
DELISTED
CASI Pharmaceuticals
CASI
| $36K | 0.02% |
2,000
-500
| -20% | -$9.5K |
2013 Q2
1 quarter
|
|
|
GLOI
207
DELISTED
GlobalOptions Group, Inc. New Common Stock
GLOI
| $36K | 0.02% |
+10,000
| New | +$36K |
2013 Q3
0 quarters
|
|
208
FuelCell Energy
FCEL
$1.31B
| $32K | 0.02% |
+6
| New | +$32.6K |
2013 Q3
0 quarters
|
|
|
PLM
209
DELISTED
PolyMet Mining Corp.
PLM
| $30K | 0.02% |
3,750
+1,250
| +50% | +$9.99K |
2013 Q2
1 quarter
|
|
|
REN.WS
210
DELISTED
RESOLUTE ENERGY CORPORATION WARRANTS EXP 09/25/2014
REN.WS
| $26K | 0.02% |
119,900
-5,000
| -4% | -$1.38K |
2013 Q2
1 quarter
|
|
|
FOH
211
DELISTED
FREDERICKS HOLLYWOOD GROUP INC
FOH
| $26K | 0.02% |
125,000
| – | – |
2013 Q2
1 quarter
|
|
212
DELISTED
PATIENT SAFETY TECHNOLOGIES, INC
PST
| $25K | 0.02% |
+13,500
| New | +$25K |
2013 Q3
0 quarters
|
|
|
213
DELISTED
Citigroup Inc
C.WS.A
| $19K | 0.01% |
25,000
| – | – |
2013 Q2
1 quarter
|
|
|
BAXS
214
DELISTED
BAXANO SURGICAL INC COM STK (DE)
BAXS
| $14K | 0.01% |
+10,000
| New | +$18.6K |
2013 Q3
0 quarters
|
|
|
DVOX
215
DELISTED
DYNAVOX INC CL A COM STK (DE)
DVOX
| $13K | 0.01% |
150,000
| – | – |
2013 Q2
1 quarter
|
|
|
EMIS
216
DELISTED
EMISPHERE TECHNOLOGIES INC
EMIS
| $5K | ﹤0.01% |
25,000
| – | – |
2013 Q2
1 quarter
|
|
|
217
DELISTED
CITIGROUP INC WTS EXP (10/28/2018) (DE)
C.WS.B
| $4K | ﹤0.01% |
50,000
| – | – |
2013 Q2
1 quarter
|
|
218
DELISTED
INDIA GLOBALIZATION CAPITAL, INC. WTS EXP 3/06/2017
IGC.WS
| $2K | ﹤0.01% |
157,798
| – | – |
2013 Q2
1 quarter
|
|
219
Acacia Research
ACTG
$424M
| – | – |
-17,300
| Closed | -$387K | – |
|
220
Archrock
AROC
$5.32B
| – | – |
-20,000
| Closed | -$562K | – |
|
221
PUT
BlackBerry
BB
$4.96B
| – | – |
-20,000
| Closed | -$209K | – |
|
|
222
Citigroup
C
$221B
| – | – |
-54,000
| Closed | -$2.59M | – |
|
223
WisdomTree Japan Hedged Equity Fund
DXJ
$2.38B
| – | – |
-15,000
| Closed | -$228K | – |
|
224
CALL
Vivmark Residential
VMRK
$47.4B
| – | – |
-20,000
| Closed | -$1.16M | – |
|
225
iShares MSCI Japan ETF
EWJ
$23.7B
| – | – |
-2,500
| Closed | -$112K | – |
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2013 Portfolio in Review
As of Q3 2013, E.E. Geduld held 392 positions worth $164M, up 16% from $141M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
E.E. Geduld's Q3 2013 filing shows 88 new, 30 increased, 44 reduced and 76 closed positions. Its largest new stake was IVERIC bio, Inc. Common Stock: 50,917 shares worth $1.51M. The largest sale was Citigroup, an estimated $2.59M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- E.E. Geduld's largest Q3 2013 buy was IVERIC bio, Inc. Common Stock: 50,917 shares worth $1.51M.
- E.E. Geduld added most to PHARMACYCLICS INC in Q3 2013, an estimated $777K increase.
- E.E. Geduld's biggest Q3 2013 reduction was Columbia Banking Systems, cutting an estimated $1.35M.
- E.E. Geduld fully exited Citigroup in Q3 2013, selling an estimated $2.59M.
- E.E. Geduld's ten largest holdings make up 37% of its $164M portfolio in Q3 2013.
- E.E. Geduld opened 88 new positions and closed 76 in Q3 2013.
- E.E. Geduld's portfolio value rose 16% quarter-over-quarter to $164M.
Based on E.E. Geduld's 13F filing for Q3 2013, filed 31 Oct 2013.